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MEDICAL SUPPORT AND FINDINGS OF THE SKYLAB PROGRAM
By Richard S. Johnston and Lawrence F. Dietlein 1M. D.
Lyndon B. Johnson Space Center
SUMMARY
One of the prime objectives of the Skylab Program was to study the long-
term effects of weightless flight on man. To carry out these investigations, a
series of medical experiments was devised to study the physiological performance
of body subsystems to provide an in-depth understanding of the adaptive changes
that may occur as a function of mission duration and the alterations that might
take place during the phase following reentry as the body readapts to activities
in the one-g field.
The Skylab results indicate that humans can perform well during long-term
space flight if they receive proper nourishment, exercise regularly, and get suf-
ficient sleep. The design of the Skylab workshop also verified that man can work
and live in the weightless environment with properly designed equipment.
INTRODUCTION
A major Skylab goal was to learn more about man and his responses to
the space environment during missions lasting as long as 84 days. The results
to date are necessarily preliminary because of the short time that has elapsed
since the end of the program. In-depth cross-correlation of the voluminous multi-
disciplinary data will be completed by specialized working teams.
The Skylab medical experiments were conceived 6 to 8 years before the
launch and remained essentially unchanged throughout the program. These
studies have added immeasurably to our understanding of man, his physiological
responses to and his capabilities in space. In one sense, the Skylab Pro-
" gram is the beginning of an in-depth study of man in this unique environment,
because the Skylab manned missions have resolved some problems while inevita-
bly raising some new questions.
This is a summary report briefly describing the medical support designed
for the Skylab Program and the significant findings resulting from medical studies
conducted during the 28-, 59-, and 84-day Skylab missions. The detailed bio-
medical results of the Skylab Program are published in a NASA report. "The
Proceedings of the Skylab Life Sciences Symposium" (NASA TM X-58154), a
two-volume NASA Technical Memorandum covering the Aug. 27-29, 1974, confer-
ence at the NASA Lyndon B. Johnson Space Center, can be obtained from the
National Technical Information Service, Springfield, Virginia 22151, at a cost
of $11. 25.
As an aid to the reader, where necessary the original units of measure
have been converted to the equivalent value in the Systerne International d'Unites
(SI). The SI units are written first, and the original units are written parentheti-
cally thereafter.
PROJECT MERCURY - 1961 TO 1963
To view the Skylab medical data in their proper context, it is helpful to con-
sider the medical aspects of the space program from an historical perspective. In
1961, both the United States and the U .S .S .R. were placing animals into orbital
flight. The goal of these flights was to refute untested but plausible theories of cat-
astrophic failures in various vital functions when such animals were suddenly thrust
into weightless flight. Besides weightlessness, there are additional stresses to be
dealt with in space; the most important of these are ionizing radiation, temperature
and humidity, accelerations, circadian rhythm disruption, noise and vibration ,and
atmospheric composition. The factor of the greatest concern to man with his many
gravity-influenced body systems was and continues to be null gravity. Many dire
effects (some of them diametrically opposed) were postulated as direct consequences
of exposing man to null gravity. Some of these predictions were anorexia, nausea,
disorientation, sleepiness, sleeplessness, fatigue, restlessness, euphoria, halluci-
nations, decreased g tolerance, gastrointestinal disorder, urinary retention, diuresis,
muscular incoordination, muscle atrophy, demineralization of bones, renal calculi,
motion sickness, pulmonary atelectasis, tachycardia, hypertension, hypotension,
cardiac arrhythmias, postflight syncope, decreased exercise capacity, reduced
blood volume , reduced plasma volume, dehydration, weight loss, and infectious
illnesses. A few of the predictions were later shown to be valid medical problems;
happily, the majority were not substantiated by flight experience.
The first indications of cardiovascular or circulatory impairment related
to U. S. space flights were the orthostatic intolerances exhibited by the pilot
of the Mercury-Atlas 8 mission following his 9-hour flight and by the pilot of
the Mercury-Atlas 9 mission after his 34-hour flight (ref. 1). Cardiovascular
data from the last and longest Mercury flight included orthostatic intolerance
and dizziness on standing, weight loss (dehydration), and hemoconcentration.
GEMINI PROGRAM - 1965 TO 1966
The biomedical studies conducted during the Gemini Program evaluated
the magnitude of flight-related changes first noted in the longer Project Mercury
flights and the other physiological changes that might occur in Earth-orbital
flights of durations up t02 weeks. Heavy emphasis was placed on evaluation
of the cardiovascular system because the principal changes observed during
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Mercury flights involved alterations in cardiovascular reflexes that regulate
blood flow under a continuous hydrostatic gradient in the Earth gr-avity field.
The preflight, in-flight, and postflight studies conducted during the Gemini
Program were intended. to detect alterations in the functional status of the principal
human body systems with increased flight duration. The results of these studies
(refs. 2 and 3) indicated that some of the major human physiological systems
undergo consistent and predictable changes as a result of space flight. The
significant biomedical findings of the Gemini Program were a moderate loss of
red cell mass, moderate orthostatic intolerance , moderate loss of exercise capacity,
minimal loss of bone density, minimal loss of bone calcium and muscle nitrogen, and
a high metabolic cost for extravehicular activity (EVA). These findings confirmed
the orthostatic intolerance observed during Proj ect Mercury and identified other
minor problems,
APO LLO PROGRAM - 1968 TO 1972
In the 5-year span of the Apollo Program, 11 manned missions were com-
pleted: 4 prelunar Apollo flights (missions 7 to 10) , the first lunar landing (mis-
sion 11), and 6 subsequent lunar exploratory flights (missions 12 to 17). The
Apollo 13 mission did not complete its lunar landing because an oxygen tank
exploded in the service module. It returned to Earth after a partial lunar orbit.
Biomedical studies during the Apollo Program were limited essentially
to the preflight and postflight mission phases, with in-flight monitoring and obser-
vations. Vestibular disturbances were added to the significant biomedical findings
incident to space flight during the Apollo Program.
Vestibular disturbances with nausea were noted by a Soviet cosmonaut
during the 25-hour 18-minute Vostok 2 flight on August 6, 1961, and by the crews
of later Soviet flights. No American astronauts had experienced any motion sick-
ness symptoms until the early Apollo experience. In retrospect, however, the
anorexia and reduced caloric intake observed on certain Gemini flights and later
Apollo flights may have been early symptoms of vestibular disturbance. Thus,
an additional problem area was introduced into the American space experience.
This disturbance had long plagued the Soviet crewmembers and had been predicted
in the early 1960's as a probable effect of weightless flight. Its belated appearance
in the American space program probably was related to the relative immobility
of the crewmen during Mercury and Gemini flights and to the absence of any
rotation of the vehicles.
The biomedical findings in the Apollo Program generally confirmed the
Gemini results of postflight dehydration and weight loss, postflight orthostatic
tolerance decrease, and postflight reduction in exercise capacity. In addition,
the decreased red cell masses and plasma volumes noted during the Gemini Pro-
gram were confirmed but were less pronounced during Apollo.
One final observation deserving mention was the Apollo 15 cardiac arrhyth-
mia episode. One of the crewmembersexperienced a single run of bigeminy
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during the mission - the first significant arrhythmia observed during any American
space flight up to that time. Two short bursts (9 and 17 beats) of nodal tachycar-
dia were observed in the astronaut during the postponed Mercury-Atlas 6 launch
attempt in 1962. At the time of the arrhythmia, the astronaut was lying in his
couch preparing for the final countdown. No arrhythmias were subsequently
observed either during the flight or following the historic 5-hour orbital flight.
In the case of the Apollo 15 astronaut, it was first thought that a dietary
deficiency of potassium might have been a contributory factor. Subsequent care-
ful analysis of their mineral intake and mission simulation studies failed to prove
this. The etiology remains obscure. Fatigue following vigorous lunar surface
activities certainly was a factor. Other contributory factors are speculative
and are likely to remain so.
SKYLAB PROGRAM - 1973 TO 1974
In assessing the biomedical effects of weightlessness on man during pro-
longed space flight, investigators are not examining absolute effects or responses.
Clearly, man is not vegetating in space but is actually doing his utmost to maintain
a high level of physical fitness and performance. Thus, the absolute detrimental
effects of null gravity will, in most cases, have to be determined through the
use and study of animals. Other points worth emphasizing are (1) that the princi-
pal studies or measurements made on space missions (including Skylab) are
relatively inflexible once the conceptual design has been finalized and (2) that
space-flight investigations are essentially field studies complicated by many
attendant difficulties, in which the investigator is even farther removed from
the experiment and the subject than in field studies on Earth. Finally, although
the measuring equipment is highly reliable in performance and the astronaut
is a superbly trained, perceptive scientist/observer in his own right, the circum-
stances fall short of the classical picture of the experimenting scientist in his
fully equipped laboratory, constantly fine-tuning his equipment and personally
performing experimental trials and collecting precious data. Despite these con-
straints, the efforts of the Skylab investigative team have resulted in a major
contribution toward understanding man in his new environment.
The Skylab Program originally was called the Apollo Applications Program.
The development of the medical experiments was initiated in the mid-1960's.
The results from the Gemini Program were used to establish the studies required
for various body systems. From this systems approach, individual experiments
were developed to study the cardiovascular, musculoskeletal, hematologic, vestib-
ular, and metabolic systems in the body.
The Skylab medical program met or exceeded all the planned objectives.
Medical operations were conducted without major problems, and the medical
equipment functioned flawlessly. The medical data received from the crewmembers
were of high quality, and the complex computer reduction of this information
was excellent. The quantity of information available from the three manned Skylab
missions is staggering. Some investigators consider their results preliminary
at this point, and the Skylab medical team must continue to integrate the results
of individual studies to give a more comprehensive total understanding of what
these data really mean. The Skylab results represent a significant stage in the
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development of space medical knowledge. Man can fly longer missions as required
for future space exploration with greater confidence as a result of the Skylab
Program medical results. The Skylab crewmen have demonstrated the versatility
and ingenuity of man to make repairs, to carry out observations, and to conduct
scientific studies.
OPERATIONAL EQUIPMENT
Several major medical subsystems were provided in the Skylab orbital
workshop (OWS) to sustain the crewmen, to protect their health, and to support
the medical studies.
The Skylab food system (fig. 1) was developed to provide a balanced and
palatable diet that also met the necessary requirements for calories, minerals,
and other related constituents of the metabolic balance experiment. Seventy
foods were available from which the crew could select their in-flight diets. Food
types included frozen, thermostabilized , and freeze-dried foods. Menus were
FOOD TRAY
FOOD PREPARATION
GALLEY
AMBIENT FOOD
STOWAGE
HIGH-DENSITY
FOOD BARS
Figure 1. - Skylab food system.
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planned for 6-day cycles. The crewmen were required to consume their planned
food menus for 21 days before flight, throughout the flight, and for 18 days after
flight.
Approximately 900 kilograms (l ton) of food was stowed in the OWS at
launch to provide approximately 400 man-days of food with approximately 10
percent overage. The ambient-temperature food was stowed in packages that
contained a 6-day supply. The packages were moved by the crewmen to the
galley area for intermediate stowage, preparation, and consumption. The galley
area contained a freezer, a food chiller, and a pedestal that provided hot and
cold water outlets, attachment point~ for three food trays, and restraints to
permit each crewman to sit while eating. The food tray contained seven recessed
openings for cans or other containers; three of these openings had heaters for
warming the food. The food cans were designed with plastic membranes or other
devices to restrain the food in zero g and to permit the crewmen to eat with
conventional tableware. Drinks were packaged in powdered form in a bellows
container with a drinking valve. Water was added from hot or cold water outlets,
and the crewmen drank from the containers by collapsing the bellows. The variety
in foods and the general design of the food system were acceptable to the Skylab
crewmen. At the suggestion of the Skylab 2 crewmen, more and varied spices
were included in the later missions to improve food flavor. The extension of
the Skjtlab 4 mission for an additional 28 days required that 113 kilograms (250
pounds) ,of!'ip.ditiollal Sky~ab food would have to be launched in the command
module (eM). This food weight and the resulting stowage volume were excessive,
and it was therefore determined that a high-density, high-calorie-type food bar
would be stowed in the GM to provide the caloric requirements formifi)sion exten-
sion. The in-flight menus Were mpdified to include the higl1~c~19l,'~~.parswith
a food energy equivalent to~ppr0J5imately3350 tofl~onkilojoules (800 to 1000
kilocalories) eaeh~lfl.y, .F?rtltE:l ~~ylab 4. mission\~pproximately 45~il~grams
(l00 pounds) of S~ylab Joodanddrinks and 23 kilograms (50 pounds) of the
high-calorie-type food bars Were launched in the eM.
Waste Mqr)ag~rnent System
The Skylab waste management system (fig. 2) included equipment for
the collection, measurement, and processing of all urine and fecal material and
for the management of waste such as equipment wrappers and food residues.
The waste management compartment coI1tained equipment used by the crew for
the collection of urine and feces. Personal hygiene equipment was also stowed
and used in this compartment. Fecal material was collected in bags attached
under a form-fitted seat. The bag was' permeable to gas but not to liquids. An
electric blower actuated by the crewmen during use provided a positive airflow
around the perineal area to carry the feces into the collection bag. Aftereach
defecation, the crewmen weighed the stool on a mass-measuring device and placed
the fecal bag into a vacuum drying processor. After 16 to 20 hours, the .fecal
residue was removed and stowed for return to Earth for postflight analysis.
Urine was collected in a 24-hour pooling bag. A centrifugal fluid/gas
separator, actuated at the start of urination, created a positive airflow to carry
the urine into a liquid/ gas separator where urine was separated and transferred
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Figure 2. - Skylab waste management system.
into the pooling bag. A measured quantity of lithium chloride was added to each
pooling bag before flight to permit calculation of urine volumes based on lithium
dilution. In addition, the crewmembers used a gage to measure pooling bag
thickness and thus provided real-time estimate of daily urine output. Each 24
hours, the crewmen collected 120 milliliters of urine from the pooling bags and
placed these samples in a freezer for return and postflight analysis. Theused
pooling bag was discarded, and a new bag was installed for use each day.
Debris accumulated from food wrappers, equipment bags, towels, and
so forth was discarded through an airlock into a large-volume tank in the OWS .
The waste management system and trash airlock operated satisfactorily through-
out the Skylab missions, and the crews reported complete satisfaction with the
design of this equipment.
Operational Bioinstrumentation
Operational bioinstrumentation (fig. 3) was used by the three crewmen
for certain critical mission phases such as launch and EVA. This system provided
electrocardiogram (ERG) and respiratory data. Electrodes were affixed to the
body and signal conditioners were contained in a belt worn on the undergarment.
Throughout the Skylab Program, high-fidelity medical data were obtained, and
the crewmen did not report any major problem with this system.
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Figure 3. - Skylab operational
bioinstrumentation.
Personal Hygiene
Provisions were included in the OWS
for daily personal hygiene. Wet wipes,
towels, toothbrushes, razors, deodorants,
et cetera were provided to maintain body
cleanliness. In addition, a shower (fig.
4) was provided to allow full body bath-
ing. Warm water and liquid soap were
available in limited quantity for one show-
er a week for each crewman. The shower
head was contained in a collapsible
cylindrical cloth bag. The Skylab crew-
men reported satisfaction with the shower
and other personal hygiene equipment;
however, they indicated that too much
time was required to collect the water and
dry out the shower after use. Analysis
of microbiological samples taken in flight
from the Skylab crewmen indicate that
the personal hygiene techniques used
were quite adequate.
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Figure 4. - Skylab shower in flight
use.
In-Flight Medical Support System
The in-flight medical support sys-
tem (fig. 5) was designed to pr-ovide first-
level medical diagnosis and treatment for
the Skylab crew as required. The sys-
tem was stowed in the wardroom and
included diagnostic, minor surgery, den-
tal, catheterization, and bandaging equip-
ment. Microbiological equipment to col-
lect airborne and surface samples during
flight was also provided. Petri dishes,
an incubator, a microscope, and a slide
stainer were available. Sixty-two medi-
cations were stowed in modules for the
three missions to ensure an adequate and
fresh supply. Before flight, all Skylab
crewmen underwent appropriate sensitiv-
ity testing for medications' they might
require during flight. The Skylab crew-
men underwent 80 hours of paramedical
training in the use of the in-flight medi-
cal support system.
Figure 5. - Skylab in-flight medical support system.
Cardiovascular Counterpressure Garment
Cardiovascular counterpressure garments (fig. 6) were launched in the
OWS for all three manned Skylab missions. These garments were designed to
provide mechanical counterpressure to the lower extremities to reduce the postural
hypotension effects following landing and operation under one-g conditions.
The garment had a partial-pressure suiflike capstan along each leg. Inflation
of the capstan by a pressure bulb provided a pressure gradient of 11 331 to
11 997 N1m2 (85 to 90 torr) at the ankles to 1333 N/m2 (10 torr) at the waist.
The garments, donned by the crewmen before entry and inflated after landing,
were used to provide protection during the postrecovery period. Inflation of the
suits had a salutary effect on the signs of orthostatic intolerance (heart rate and
blood pressure) .
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Figure 6.- cardiovascular counterpressure p'arrrlerlt
SKYLAB MEDICAL OPERATIONS
The medical operational planning for Skylab was much more complex than
for any previous U . S. manned space mission. The logistics planning required
for combining crew feeding, sample collection, baseline experiment data acquisi-
tion, crew medical examinations, crew health care, data processing, and flight
management into an integrated plan that meshed with program milestones required
a major medical team effort. The Skylab medical operations program (fig. 7)
was initiated in June 1972 with a 56-day altitude chamber test; it was completed
in April 1974 with the final postflight evaluations on the Skylab 4 crew.
The compression of the Skylab launches and the extension of the mission
duration created an extremely heavy burden on the Skylab medical team. The
medical exper-iments program was unique in that it not only provided scientific
data but also served as the basis for real-time operational decisions for the
commitment to longer duration flights. This meant that, at the end of the first
two missions, the medical team had to make a recommendation on the extension
for the next mission. The Skylab 3 preflight phase began before the Skylab 2
postflight phase was completed and after the preflight data collection for Skylab
4 had begun. The Skylab 3 mission was launched only 2 weeks after the Skylab
10
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2 postflight studies were completed; Skylab 4 was launched only 5 weeks after
completion of the Skylab 3 postflight medical studies. This quick turnaround
required careful planning, establishment of priorities on samples and data process-
ing, and dedication and tireless effort from all members of the medical team.
The Skylab medical experiment altitude chamber test (fig .. 8) was a 56-
day mission simulation performed in a 6.I-meter (20 foot) diameter vacuum
chamber , The internal chamber arrangements were similar to the OWS crew
quarters level, which contained the medical experiments area, the wardroom,
the waste management compartment, the sleeping quarters, .an.d the recreational
areas. The prime objectives of the test were to acquire background data and
to exercise the data management and proeesstng techniques for Selected medical
experiments. The atmosphere in the chamber was maintained ata composition
identical to that of the OWS, with a 70-percent-oxygen, 30-percenh-nitrogen
m!~t~re at 34 474 N/m 2 (5 p~ia). Carbon dioxide levels were controlled at a
rl()rr)inallevel of 667 N/m2 (5 torr). Other test objectives included the evaluation
ofmedical experiment and operational equipment, the .evaluation ofoperational
procedures, and the training of support personnel under simulated mission
conditions. Using the actual flight mission as a model, the test consisted of
ACTIVITY
M
56-DAY
ALTITUDE
CHAMBER TEST
ORBITAL
WORKSHOP
FIRST
MISSION
(SKYLAB 2)
SECOND
MISSION
(SKYLAB 3)
THIRD
MISSION
(SKYLAB 4)
c:::::JEXPERIMENTS BASELINE ACQUISITION
(::;:;:;:;:;:;:;1 PREFLIGHT PERIOD
~IN-FlIGHT
~POSTFLIGHT
Figure 7 .. - Skylab medical operations program.
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Figure 8. - Skylab medical experiments altitude test.
a 21-day prechamber phase, a 56-day chamber test, and an 18-day postchamber
test period. All preflight and postflight medical protocols were performed using
astronaut crewmen as subjects. The in-chamber test portion of the program was
carried out under full mission simulation procedures and included the crew check-
list, real-time mission planning, and data management. Communications with
the crewmen were limited to one spacecraft communicator as carried out in the
missions. Simulated network communications also were followed to evaluate
the problems of loss of communication between the flightcrews and the mission
control center that could be experienced in actual flight. A remote console was
used by the medical team to develop and implement ground control procedures
for flight. This test program was quite successful. The required baseline data
were obtained, and equipment failures and problems were encountered that were
corrected before flight. The ground support personnel became an effective team
ready to carry out the complex flight program.
Premission Support
The premission support for the first manned mission started in December
1972 with the acquisition of the first baseline data for the lower-body negative-
pressure (LBNP) and metabolic activity experiments (fig. 9). Additional baseline
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•••
Figure 9. - Skylab preflight operations (typical mission) .
tests were conducted in support of the medical experiments at designated periods
up to approximately 1 week before lift-off. The baseline data were primarily
obtained in an OWS one-g trainer. This full-scale trainer contained fully functional
medical experiments and other operational hardware. Crew training and baseline
data collection were combined for both the prime and the backup crewmen.
A remote medical console and a data recording system were used to monitor the
crewmen during training sessions and to train members of the medical team in
l control procedures and flight data reduction. This combination training and
medical baseline data acquisition provided excellent experience for both the
crewmen and the medical experimenter.
A comprehensive medical examination was performed on both the prime
and backup crews 30 days before the scheduled launch, and additional baseline
data were obtained for the experiments. The crewmen were placed in semi-isolation
21 days before lift-off to meet the requirements of a health stabilization program.
The objective of this program was to protect the flightcrews from illnesses that
might cause them to be removed from flight status and to preclude the occurrence
of infectious disease in flight. All personnel who were required to work with
the flightcrews were designated as primary contacts. To protect the crewmen,
these individuals underwent extensive medical examinations and immunizations
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and were required to report all personal and family illnesses. Those primary
contacts who would come into direct contact (within 2 meters) with the crew were
medically screened each day and were required to wear surgical masks while
in contact with the crew. Isolated crew quarters were established, and personnel
access to.designated primary work areas was rigidly controlled. The Skylab
health stabflization program was quite effective, and no major problems were
encountered.
During the isolation period, the flightcrew and backup crew diet was identi-
cal with the menus provided during flight. Daily collections of urine and fecal
samples were also initiated. Medical examinations, microbiological and blood
sampling ,and experiment baseline tests were continued at the NASA Lyndon
B. JOhnson Space Genter up to 3 days before lift-off. At that time, the prime
and backup crews moved to the NASA John F. Kennedy Space Center for the
launch.
In-Flight Operational Support
The management of the in-flight medical operations support and the neces-
sary interactions with program management, other scientific disciplines , .and
the flight control team were accomplished through a medical management group.
This medical group met each morning of the mission to review crew health status ,
to evaluate the current status Of the medical studies, to discuss equipment or
other operational problems, and to establish changes in experiment priorities.
Health trend charts were plotted each day to provide experimental data that were
useful in understanding crew health status. These charts included crew weight,
caloric intake, quantity of sleep, heart rate and blood pressure under dynamic
stress, urine volume output ,and other pertinent information. The chairman
of this medical group reported to a Flight Management Team on all medical matters
and participated in operational decisions such as changing crew time lines, adjust-
ing science requirements to ensure maximum use of crew talent and energy and
of current science opportunities, and providing advice on major operational
policy changes. This management scheme was extremely effective and was an
important factor in the success of the Skylab Program.
Thein-flight activities of the first manned Sky-lab mission are shown in fig-
ure 10 to illustrate the medical events for a typical Skylab mission. The first 2 to
3 days of each mission were spent in activation of the OWS. This operation included
such tasks as system checkouts and activation, transfer of equipment from the CM to
the OWS, and changing air filters. In-flight medical monitoring of the crew started
at launch through the use of the operational bioinstrumentation system. During all
EVA1s, the crew was monitored utilizing this same system. The frequency of in-flight
medical experiments for the Skylab 2 crewmen indicates the points at which various
studies were performed or biological samples obtained during this mission. On all
Skylab missions, the LBNP and the metabolic activity experiments were accomplished
on approximately the fourth day of flight. Blood samples were collected weekly
during the missions, and urine biosampling was done daily.
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MISSION DAYS
ACTIVITY 1121314151617181911011111211311411511611711811912012112~23124125126127128
WORKSHOP ACTIVATION~
IIOMONITORING ~ • •EVA EVA
EXPERIMENTS:
LOWER BODY
NEGATIVE PRESSURE • • • • • .. • •
METABOLIC ACTIVITY • • • • • • •
VESTIBULAR STUDIES •• •• • ••
SLEEP STUDY •• • • • • • •
ILOOD SAMP,LlNG • • • •
1I0SAMPUNG .- -,EVERY DAY
CIICADIAN SHIFT ....
DEAC'IVA'ION ~
Figure 10. - Skylab in-flight medical support program.
During the flight phase. real-time monitoring of the medical experiments
was accomplished only when the spacecraft was over a tracking station. Insome
instances. this meant a complete loss of communication with the crew and a loss
of telemetered data during medical testing. To overcome this problem. all experi-
ment data were recorded on board and subsequently telemetered through the
tracking stations to the mission control center. Software programs were used
to enable automatic computer reduction of the experiment data. The experimenters
had a preliminary data printout within 24 hours after completion of an experiment
test. During the latter part of all three Skylab manned missions. work/rest
cycles were altered to adjust the length of the day before entry and the time
of spacecraft landing.
The in-flight portion of the three Skylab manned missions lasted 171 days
over an 8. 5-month period. Throughout this long and arduous period. the interest.
enthusiasm. and concern for the crews was maintained at the highest level by
all members of the medical and the pr:ogram management teams.
Postflight Activities
The recovery of the Skylab crewmen differed from the Apollo recoveries
in several respects. The eM with the crewmen onboard was retrieved by the
recovery aircraft carrier and was lifted directly on board. The crewmembers
came out of the spacecraft onto a platform on the hangar deck. Spacecraft and
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crew retrieval took approximately 35 minutes from the time of splashdown. Special-
ized mobile laboratories were developed and equipped to acquire preflight and
postflight medical experiments data. Six laboratories made up the complex.
The laboratories were designed and made to be moved in a C-5A transport aircraft
to enable the medical team to cover contingency landings if an early mission abort
occurred. For a normal mission, the laboratories were flown to port and lifted
onboard the recovery carrier. The mobile laboratories were designed with
backup support systems such as electrical power, heating, and cooling. In addi-
tion, a central data unit was included to enable processing of medical data in a
format compatible with the flight data. In use, the mobile laboratories proved to be
excellent support facilities which expedited in large measure the conduct ofpost-
recovery medical operations. The laboratories operated without problems and. pro-
vided medical data of the highest fidelity.
Medical studies were initiated immediately after recovery operations. A
summary of all postflight activities is shown in figure 11. For the Skylab 2 mis-
sion, the recovery day (R+O) testing lasted for approximately 10 hours and in-
cluded a comprehensive medical examination as well as the acquisition of data
for all major medical studies. In subsequent missions, the length of the R+O
medical studies was shortened to reduce the crew day. The health stabilization
DAYS FROM RECOVERY
ACTIVITY
011 I 213141S161 71 81911011111211311411SI16117118~21\16O
MEDICAL A AEXAMINATION
HEALTH STABILIZATION
I
MICRO SAMPLING A A A
FOOD AND
BIOSAMPUNG I
BLOOD SAMPLING AAA A A A
EXPERIMENTS: AAA A ALOWER BODY
NEGATIVE PRESSURE
METABOLIC ACTIVITY AAA A A
VESTIBULAR STUDIES AAA A A
SLEEP STUDIES AAA
Figure 11. - Skylab postflight medical activities.
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program was in force throughout the first week following recovery to protect the
crews from infectious disease that might result from depressed immune responses
after the relatively long isolation periods of the Skylab flights. Microbiological
sampling, blood sampling, and biosampling were accomplished as shown in figure
11. Medical studies were completed on the days indicated. In all Skylab missions,
medical testing was continued until preflight control levels were reached.
OPERATIONAL EXPERIENCE
The launch of the OWS on May 20, 1973, and the subsequent failures impacted
the medical program. The loss of the micrometeorite shield exposed the skin
of the OWS , causing an increase in OWS temperatures. The partial deployment
of the solarpanels reduced the electrical power supply available for experiments
and systems operations. The OWS failure also resulted in a 10-day delay in the
launch of the. first manned mission (Skylab 2), which meant that health stabilization,
controlled feeding, and biosample collection periods had to be extended. The expo-
sure of the OWS skin caused an elevation in both wall and spacecraft-air tempera-
tures. The temperature increase for the early phase of Skylab is shown in figure
12. Maximum temperatures in this food stowage area exceeded 328 K (130° F). In
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the to-day period before the launch of the Skylab 2 mission, a thermal screen was
developed that the crew could deploy to shield and insulate the OWS. In the inter-
vening period, however, the increase in temperature raised several questions for
the medical team. Would the foods be spoiled or changed by the elevated temperature?
Would other medical equipment be damaged by the increased temperature? Would the
polyurethane walls of the OWS be heated to a point at which carbon monoxide (CO)
or toluene diisocyanate (TDI) would be emitted into the spacecraft atmosphere?
Immediate action was taken to perform ground-based test programs and to develop
data and equipment that the crewmen could use to understand and/or to solve the
possible problems.
Food test programs were initiated to study the effects of the increased
temperature on microbial growth, food quality, and other characteristics. Identi-
cal foods were placed in thermal chambers and actual temperature data from the OWS
were used for the thermal test profile. Periodic food sampling was accomplished to
determine the biological and chemical composition changes and the effects on taste
and palatability. No significant food failures were encountered during these
tests, and the launch of the first manned mission proceeded without major altera-
tions to the food system. The food test program was continued throughout the
Skylab Program, however, and selected food samples were returned from the
three missions for analysis.
Similar thermal testing was accomplished for many miscellaneous medical
items, such as electrode sensors and sealed containers. The determination was
made from these tests that certain medications should be resupplied by the Skylab
2 crewmen. Additional procedures and equipment were developed to allow the
crew to replenish the conductive gel of the electroencephalogr-aph (EEG)
electrodes on the sleep study caps.
The potential toxicity problems associated with the OWS polyurethane wall
insulation also were studied through thermal testing. It was determined that
TDI and CO could have been present in the atmospher-e. Before the launch of
the first manned mission, equipment was provided in the OWS to monitor the
OWS atmosphere for CO. Detector tubes and a pump were provided to enable
the crewmen to determine CO levels by colorimetric comparison. Following
the launch of the OWS, it was determined that additional trace gas detectors
should be provided. Special tubes and adapters were built during the 10-day
period between the launch of the OWS and the first manned mission. This equip-
ment permitted the crew to withdraw an atmospheric sample from the airlock
and then from the OWS before opening the hatch into these areas. In addition,
special masks were provided to enable the crew to move into the OWS if the TDI
and/or CO levels became toxic. The Skylab 2 crew found no TDI, and the CO
concentration was less than 5 ppm.
The crew deployed the thermal screen on the second day of the first manned
mission and the OWS wall temperatures began to decrease immediately. Within
several days, the ambient gas temperature had dropped below 300 K (80 0 F) .
The elevated temperature in the OWS did delay the start of some medical experi-
ments and undoubtedly influenced the results of the first medical studies; however ,
through the ingenuity of man and the efforts of the Skylab 2 crewmen. the mission
and the workshop were saved from what appeared to be an obvious total failure.
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Throughout the Skylab flight program, alterations in equipment and proce-
dures were made to capitalize on the flight experience of the previous mission.
The Skylab 2 crew recommended that the personal exercise program in flight
be expanded in both duration and exercise type. To meet this recommendation,
the exercise period for the Skylab 3 crew was expanded from 0.5 to 1 hour daily,
and an additional exercise device was launched for the Skylab 3 crew. During
the Skylab 4 mission, the duration of crew exercise was further expanded to
1.5 hours daily, and a unique treadmill device was used by the crewmen. The
first crew also recommended that food palatability could be improved by the addi-
tion of spices. As a result, commercially available spices such as garlic salt,
hot pepper, and similar condiments were carried by the Skylab 3 crewmen.
For the Skylab 4 mission, liquid spices were carried to overcome problems the
Skylab 3 crewmen had using the conventional spice dispensers in the weightless
environment.
In addition to these equipment-associated changes, additional medical
studies were added to both the Skylab 3 and 4 missions; these studies are shown
in tables I and II. These additional studies demonstrate the flexibility afforded
the medical team and the support given to this team by program management
and the flightcrews.
TABLE 1.- SPECIAL IN-FLIGHT TESTS ADDED
Test Skylab 3 Skylab 4
Blood flow X X
Facial photograph X X
Venous compliance X X
Anthropometric measurements X
Treadmill exerciser' X
Center of mass X
Infrared anatomical photograph X
Taste and aroma evaluation X
Atmospheric volatile concentration X
Light flash observations X
Hemoglobin X X
Urine specific gravity X X
Urine mass measurement X
Stereophotogrammetry X
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TABLE II.- SPECIAL PREFLIGHT AND POSTFLIGHT TESTS
Test Skylab 2 Skylab 3 Skylab 4
Echocardiography X
Blood circulation time X
Postural equilibrium test X X
Venous compliance X X
Muscle strength X X X
TABLE III.- SKYLAB MEDICAL EXPERIMENTS
Number Experiment
M071 Mineral balance
M073 Biochemistry of body fluids
M074 Specimen mass measurement
M078 Bone mineral measurement
M092 Lower body negative pressure
M093 Vectorcardiogram
MUO Hematology I immunology
M131 Human vestibular function
M133 Sleep monitoring
M151 Time and motion study
MI71 Metabolic activity
M172 Body mass measurement
LIFE SCIENCES EXPERIMENTS
The Skylab medical studies listed in table III were designed along classical
lines of medical and physiological research; that is, they were grouped in related
studies according to their contributions to the understanding of the functioning
of a major body system. The results from previous space flights influenced the
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planning for and the placement of emphasis in the new program. Experiments were
developed to investigate the cardiovascular, musculoskeletal, hematologic, vestib-
ular, metabolic, and endocrine systems. The performance of major medical
experiments during flight provided a method of studying physiological changes as
a function of exposure to weightless flight in contrast to the preflight and postflight
studies performed for the Apollo missions and for all but one Gemini flight.
The equipment for the Skylab medical exper-iments (fig. 13) was located on
the crew quarters level of the two-story OWS. The equipment occupied about one-
third of the floor area of this level. The two consoles deployed against the OWS
wall housed the electronic equipment related to the medical experiments.
Cardiovascular Studies
Two experiments were performed during the Skylab missions to study the
responses of the cardiovascular system during weightless flight and on return to
Earth and the one-g environment. The first of these experiments utilized an LBNP
device to provide stress to the cardiovascular system. Continuous physiological
observations were made on the responses to this stress. A photograph of a Skylab 2
Figure 13. - Medical experiments (Skylab 3 photograph) .
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crewman in the LBNP device is shown in figure 14. The blood pressure cuff and the
vectorcardiogram sensors were attached to the crewman. The elastic waist seal per-
mitted negative pressure to be appliedto the lower extremity of the crewman. A
plot of the responses to a typical preflight protocol is shown in figure 15. The lower
curve is the negative pressure levels applied for the 25-minute test. After an initial
5-minute rest period, negative pressure levels were applied at 4000, 5333., and
6666 N/m 2 (30, 40, and 50 torr) differential pressur.e for 5-minute intervals, fol-
lowed by a 5-minute recovery period. The percentage of leg volume change furnished
an estimate of the amount of blood pooling in the legs and is an index of peripheral
vascular function. Diastolic and systolic blood pressures were measured every 30
seconds, and heart rate (obtained from the vectorcardiogram) rose from approximately
65 (baseline) to 80 beats/min at maximum negative pressure. A typical aborted
protocol occurring on mission day 20 is shown in figure 16 and illustrates a pre-
syncopal episode (early fainting symptons-- sweating, lightheadedness, and ting-
ling of extremities). In this test, 3 minutes into the .6666-N/m2 (50 torr) pressure
Figure 14. - Lower-body negative-pressure device in use.
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Figure 15. - Preflight response of Sky-
lab 3 commander during LBNP test.
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Figure 18. - First postflight response
of Skylab 3 commander during com-
pleted LBNP test.
Figure 17. - In-flight (mission day 58)
response of Skylab 3 commander dur-
ing last LBNP test.
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day 58 in the Skylab 3 mission and the
first test on recovery day is' presented in
figures 17 and 18. It is evident that the
last in-flight LBNP test response was
almost identical with that on recovery day.
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Figure 16. - In-flight (mission day 20)
response of. Skylab 3 commander dur-
ing aborted LBNP test.
level, the subject elected to stop the test be-
cause of subjective symptoms. These were
confirmed by the rise in pulse rate from
72 to 110 beats/min followed by a rapid
decrease in heart rate. Systolic blood
pressure fell rapidly and the pulse pres-
sure narrowed. A comparison of mission
.'
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Throughout each mission, daily trend charts were maintained to determine
whether significant changes in certain critical physiological measurements were
occurring as the mission progressed. In the LBNP studies, heart rates at rest, at
maximum negative pressure, and blood pressure data were plotted as a function of
mission duration. The average resting heart rates for the crewmen during each of
the three missions are summarized in figure 19. Preflight information was obtained
to establish an individual baseline. During flight, resting heart rate was stable and
slightly elevated for most crewmen. Postflight heart rates were determined in the
supine position. The heart rates under 6666 N/m 2 (50 torr) negative pressure are
shown in figure 20. In general, in-flight heart rates were elevated as compared with
preflight rates. The arrows in figure 20 indicate the termination of an LBNP test
during the flight. A total of 13 terminations occurred in 138 in-flight tests. Nine
ofthe terminations took place in the first 26 days of the missions. Heart rates at
maximum negative pressure on recovery day compared closely with those observed
during the last LBNP test during flight.
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Figure 19. - Summary trend plot of crew resting heart rate.
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,~ The second cardiovascular experiment was designed to study changes in the
electricaL activity of the myocardium by vectorcardiographic measurement during
exercise. This more comprehensive EKG provided a three-dimensional analysis of
heart muscle electrical activity. Results of this experiment have shown very minor
changes in electrical activity that are of no clinical significance. The reasons for
these minute changes are not understood at this time.
In summarizing the results of the cardiovascular system evaluation, the
following gener-alized comments can be made.
1. Cardiovascular deconditioning does occur during flight, but the change
is adaptive in nature and stabilizes after a period of 4 to 6 weeks. This change
does not impair crew health or performance in flight, and it is triggered by factors
that tend to reduce circulating blood volume.
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2. The LBNP test has proved to be a fairly reliable predictive index of
postflight ear-diovascular status'. Cardiac arrhythmias have been rare: only
one episode was noted early in the Skylab 2 missicn during intensive personal
exercise. This episode was Interpreted as bursts of multiple, unifocal, ventricu-
lar, premature beats with no evidence of coupfing .. Other. arrhythmias observed
have been limited to isolated rare or occasional pr\3mature beats . Cardiac electri-
cal activity has been within acceptable physiological limits as judged from the
vectorcardiographic data.
3 . The rapid postflight recovery of orthostatic and exeret~e tolerance
after two of the three manned Skylab missions appears to be directly related
to total in-flight exercise as well as tq t:I,~raded, regular program of exercise
during the postflight debri~fing.per.iod. The. postflight qrth913tatic intolerance
and diminished exercise capacity .l:l.re both relatedetiolog}ca~~yto a decreased
effective circulating blood volume at one g, with consequ;enLd\3creased venous
return and cardiac output. Other factor-s to be considered are muscle imbalance,
altered electrolyte flux, possible changes in venous tone or reflexes ,and fatigue.
No convincing incidence of myocardial damage as an etiological factoer exists;
however, transtentcellular changes during the period of homeostatic perturbation
would not be surprising.
Musculo?~eletal Balance and Fluid/Eleetro lyte Studies
A series of experiments was performed to study calcium and nitrogen balance
and the biochemistry of body fluids. In the mineral balance experiment, crew dietary
intake was car\3fully controlled to maintain a ne·~rly constant intake of electrolytes ,
proteins, and similar nutrients. The caloric intake level was established by
the crew befor-e flight to ensure adequate weight control and to satisfy appetites .
Daily weights (fig. 21) were obtained. em the body mass measurong device. Samples
from the pooled daily urine output of each crewman were collected and returned to
Earth with dried fecal residues for postflight analysis. Caloric intake was de-
pressed early in all mtssions. This loss of appetite probably was associated with the
motion sickness problems that occurred. Water intake- and urine output remained
relatively constant throughout all mission phases. In addition to these studies,
mineral loss in selected bones was determined by a preflight and postflight mea-
surement of bone density using a gamma ray scanning technique.
The significant findings in the musculoskeletal balance studies include the
moderate loss of calcium, phosphorus, and nitrogen observed in the first two manned
Skylab missions. Preliminary evaluation of data from the 84-:day mission tends to
support the general observation that these losses are comparable to those observed
in subjects at bed rest. The average rate of loss observed was 6 grams of calcium
per month or 0.5 percent of total body calcium per month. Complementary mineral
losses in the os calcis were relatively low. These data indicate that missions of
extended duration would be feasible without preventive or remedial measures.
The Skylab experience has provided evidence that the caloric requirements
of space flight are identical with those for the individual on Earth - at least for
high-activity missions such as Skylab. From Gemini and Apollo experience,
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it seemed that the individual in-flight ca-
loric requirement was equivalent to ap-
proximately 1260 ~JIcl~y '(300 kcal!day)
less ~l)..an the caloric reqpirement on
Earth. This judgment. mayhavcpbeenin-
fluenced by the relatively low activity
profiles of these missions and by the fact
that the food provided was often not con-
sumed . In retrospect, this anorexia may
l).aye bgen a manifestation qf early motion
sic~n~s~ that was not recognized as such
atthetiWe.
al function was unimpaired
ghfbecause of a Gpmplex inter-
9pal.and possibly hemody-
riS .: In addition, an~hropomet-
stu s performed on SkyllZl,b 4 support
phalad shiftbf body fluid$ ip zero
With regard to the musculoskeletal
$ys~eJll, the negative balances observed
Ill.redU~primarilyto the absence of grav-
tty .:· However ~ the correct combination
dfweight bearing, muscular activity,
hormonal influence, and circulatory fac-
tors required to prevent these negative
balances in bed-rest studies has not been defined at this point in time. Elevated
cortisol secretion during flight helps to confuse the picture and doubtless con-
tributes to nitrogen and potassium loss.
Sleep Studies
Sleep studies were performed on one crewman during each Skylab flight.
The EEG signals were obtained from a specially designed cap (fig. 22). The crew-
men wore the caps on selected nights in order to document sleep patterns. The EEG
signals were recorded onboard and were converted by a simple computer system
into digital telemetry signals that described the five stages of sleep. These sleep
stages range from stage 1 (light sleep) to stage 4 (deepest sleep) and include
rapid eye movement (REM) sleep or dream states. The sleep data from the three
manned missions are summarized in figure 23. The percent of a single night's
sleep spent in the various sleep stages and the total' number of hours of sleep
are shown , It is apparent that there was very little variation in the in-flight
sleep patterns of the Skylab 3 crewman. Some variations were observed for
the Skylab 2 crewman. The total number of hours of sleep was slightly reduced
for the Skylab 2 crewman during flight, while. the Skylab 3 crewman's hours
of sleep were approximately the same as before flight. These preliminary data
indicate that long-term weightless flight did not significantly alter the normal
sleep patterns of the individuals studied. The results of these studies
indicate that man is able to obtain adequate sleep during prolonged periods of
time in space. The alteration in sleep patterns observed during Skylab missions
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Figure 22. ~ Sleep-study cap worn by
Skylab 2crewrnan.
Equipment was developed and flown
to collect, process, and preserve in-flight
blood samples (fig. 24). The crewmen
acquired lO-milliliter blood samples with
a conventional syringe and then trans-
ferred the whole blood into a pr-eevacu-
ated sample processor'. ThesaI:t1ple proc-
essor was then placed in a centrifuge to
separate the plasma from the cells and to
transfer the plasma into a separate col-
lection vial for preservation. This trans-
fer operation had to be accomplished
automatically while the blood was being
centrifuged because of fluid behavior
characteristics at zero g. A cross-
sectional dr-awing of the sample proces-
sor is shown in figure 25, which also
illustrates how the equipment functions.
Whole blood is transferred from the sy-
ringe through a septum into the processor.
A spring-loaded piston is attached to the
bottom of the sample processor, and the
unit is placed in the centrifuge. During
initial centrifugation, the cells and the plasma are separated. At this point, the
centrifuge speed is increased to force the piston to drive the plasma vial septum
past a needle and allow the plasma.to flow into the vial. Following this separation, the
plasma and blood cells are placed in a freezer and preserved for postflight analysis.
was not significant and did not result in
any degradation of performance. After
flight ,the crewmen exhibited some
changes in sleep patterns that probably
resulted from the readaptation to one g.
Blood Studies
These in-flight blood samples and the preflight and postflight samples
obtained from the crewmen were processed by a team of hematologists. Results
have shown some loss in red blood cell mass, a decrease in plasma volume, and
additional minor changes that are of no clinical significance. The loss in red
blood cell mass appears to be a suppression of red cell production rather than
a destruction of cells and apparently is not related to mission duration.
Exercise Capacity Studies
The in-flight response to exercise was studied through the use of
a metabolic analyzer and a bicycle ergometer (fig. 26). In these tests, the
crewmen exercised at three speed levels, and the physiological responses
to this stress (heart rate, blood pressure, minute volume, oxygen consumption,
and carbon dioxide production) were measured. The ergometry protocol was
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Figure 23. - Summary of Skylab sleep studies.
25 minutes in duration: 5 minutes at rest, 5 minutes at each of the three progres-
sively higher work rates, and 5 minutes for recovery. In-flight results from these
tests have shown no decrease in exercise or work capacity. Oxygen consumption and
carbon dioxide production at given workloads were not altered. A plot of heart rate
at maximum exercise levels is shown in figure 27. These data indicate that heart
rate either decreased or remained stable during flight. All crewmen, however,
showed a marked decrease in their response to exercise following recovery. Except
for the Skylab 2 crewmen, this diminished exercise capacity returned to preflight
levels 4 to 5 days after recovery. The reason for this decrease in postflight exer-
cise capacity is not fully understood; however, it is believed that the apparent
pooling of blood in the venous system after flight must contribute to this response.
Vestibular Studies
Vestibular function during flight was studied through the use of a rotating
litter chair. One part of this study was the determination of susceptibility to motion
sickness during rotation in the chair at varying rates of revolution with the con-
comitant performance of a series of head motions. The crewmen were trained to
recognize the slightest symptom of motion sickness before flight, and their suscepti-
bility or threshold was determined by this method. During flight, following an
initial period of adaptation, all crewmen exhibited an increased tolerance to motion
sickness as measured by an increased tolerance to higher rotation levels and an
increased number of head motions without perceiving any motion sickness symptoms.
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Figure 24. - Skylab in-flight blood collection system.
The individuals who demonstrated the highest preflight resistance to motion sick-
ness as measured with the rotating litter chair were generally the individuals most
susceptible to motion siekness during the first few days of the missions. This
specific area. of neurophysiology requires a more detailed investigation into the ves-
tibular a.daptive process and the femulation of reliable preflight susceptibility (selec-
tion) tests. The use of anti-motion-sickness medications can provide protection to
crewmen; however, the mechanisms involved in this complex problem must be under-
stood more thoroughly.
Time and Motion Studies
In studies measuring in-flight performance capability, the crewmen were
evaluated during the performance of a predetermined set of tasks. Ground-
based studies established a baseline that permitted the investigator to evaluate
skill retention and change in performance levels. Using the LBNP experi-
ment as an example, the Principal Investigator has shown that the Skylab 4 crew
exhibited progress in decreasing the time required to accomplish this complex
experiment. By mission day 68, the crew had reduced the time required to accom-
plish the LBNP studies by 20 percent of their best preflight times.
30
Figure 25. - Skylab blood sample processor.
Figure 26. - Skylab 2 crewman performing exercise capacity study.
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Figure 27. - Summary trend.!?lot of crew heart rate responses to exercise at
maximum exercise level.
The medical experiment equipment functioned flawlessly throughout the
three manned. missions. High-fidelity medical data were obtained for all experi-
ments. Tqe vast quantity ofmedi9;al qa.ta available for red11lction and analysis
was processed in an orderly fashion ~ .:This reduction and analysis could not
have been accomplished in a reasonable time without computer assistance. The
quantity of information obtained from the medical studies conducted with the
Skylab crewmen over a relatively short time period is staggering and perhaps
unique in the annals of medical research. More than 700 000 biochemical analyses
were performed on food, blood, and urine and fecal samples. In completing two of
the major medical experiments, more than 18000 blood pressure determinations were
performed and more than 12 000 minutes of vectorcardiographic data were obtained.
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CONCLUDING REMARKS
Most of the biomedical problems predicted during the early years of manned
space flight relative to man and the space environment did not materialize during
the total 171 days of the Skylab manned missions. Those physiological alterations
that were documented by the Skylab medical experiments were generally accommo-
dative in nature and were not serious enough to impair the ability of the crewmem-
bers to work effectively in the weightless environment. In general, the Skylab
medical findings confirmed and extended those of the shorter Mercury, Gemini,
and Apollo flights.
Crewmen were carefully studied during the preflight, in-flight, and post-
flight phases of each Skylab mission. The principal findings resulting from the
intensive Skylab biomedical studies were space motion sickness during early
flight, moderate bone mineral losses comparable to those observed in man during
prolonged bed rest, moderate cardiovascular deconditioning , and reduced effec-
tive circulating blood volume as reflected by the loss of red cell mass and plasma
volume. In the early postflight phase, orthostatic intolerance was observed similar
in degree to the late-mission responses to lower body negative pressure. Exercise
intolerance was not observed during flight but was characteristic of the early
postflight period.
Despite the foregoing observations, the Skylab medical experience has
emphasized the ability of man to live and work effectively in space for extended
periods of time. Appropriate nutrition, programed adequate sleep, work, exercise
and recreation periods, and suitable work areas must be provided to maintain
crew health and well-being.
Lyndon B. Johnson Space Center
National Aeronautics and Space Administration
Houston, Texas, March 12, 1975
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